Malignancies Associated with Pediatric HIV Infection: Long Term Survivors on Highly Active Anti Retroviral Therapy(HAART) 760

被引：0
|
作者：
Ninad Desai
Scott T Miller
Edward Handelsman
Senih Fikrig
Sreedhar P Rao
Hermann Mendez
机构：
[1] Brooklyn Pediatric AIDS Network,
[2] SUNY Health Science Center at Brooklyn,undefined
[3] Div. of Pediatric Hematology / Oncology,undefined
[4] SUNY Health Science Center at Brooklyn,undefined
[5] Div of Ped. Immunology,undefined
[6] SUNY Health Science Center at Brooklyn,undefined
来源：
Pediatric Research | 1998年 / 43卷 / Suppl 4期
关键词：
D O I：
10.1203/00006450-199804001-00781
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：132 / 132
相关论文
共 50 条
  • [21] Changes in immune parameters in HIV-1 infected children during highly active anti-retroviral therapy (HAART).
    Westby, M
    Watkins, AM
    Drake, J
    Wills, B
    Cammack, N
    Sharland, M
    AIDS, 1998, 12 : S95 - S95
  • [22] Impact of highly active anti-retroviral therapy (HAART) on cytokine production and monocyte subsets in HIV-infected patients
    Amirayan-Chevillard, N
    Tissot-Dupont, H
    Capo, C
    Brunet, C
    Dignat-George, F
    Obadia, Y
    Gallais, H
    Mege, JL
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2000, 120 (01): : 107 - 112
  • [23] Influence of highly active anti-retroviral therapy (HAART) on the natural history of extra-pulmonary tuberculosis in HIV patients
    de Olalla, PG
    Martínez-González, MA
    Caylà, JA
    Jansà, JM
    Iglesias, B
    Guerrero, R
    Marco, A
    Gatell, JM
    Ocaña, I
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2002, 6 (12) : 1051 - 1057
  • [24] Improvement of onychomycosis without antifungal therapy after initiation of highly active anti-retroviral therapy (HAART) in an HIV-infected patient
    Tachikawa, N
    Yasuoka, A
    Oka, S
    JAPANESE JOURNAL OF INFECTIOUS DISEASES, 1999, 52 (06) : 245 - 246
  • [25] Highly active anti-retroviral therapy (HAART)-induced maintenance of adaptive but not innate immune parameters is associated with protection from HIV-induced mortality
    Stebbing, J.
    Bower, M.
    Mandalia, S.
    Nelson, M.
    Gazzard, B.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2006, 145 (02): : 271 - 276
  • [26] Cost of Treating Seriously Mentally III Persons with HIV following Highly Active Retroviral Therapy (HAART)
    Rothbard, Aileen B.
    Lee, Sungeun
    Blank, Michael B.
    JOURNAL OF MENTAL HEALTH POLICY AND ECONOMICS, 2009, 12 (04): : 187 - 194
  • [27] Highly active anti-retroviral therapy (HAART) is associated with a lower level of CD4+ T cell apoptosis in HIV-infected patients
    Roger, PM
    Breittmayer, JP
    Arlotto, C
    Pugliese, P
    Pradier, C
    Bernard-Pomier, G
    Dellamonica, P
    Bernard, A
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 1999, 118 (03): : 412 - 416
  • [28] HIV-associated dementia in the era of highly active antiretroviral therapy (HAART)
    Xia, Chenglai
    Luo, Dixian
    Yu, Xiaoling
    Jiang, Shibo
    Liu, Shuwen
    MICROBES AND INFECTION, 2011, 13 (05) : 419 - 425
  • [29] Preservation of genital tract T cell immunity in HIV-infected women on highly active anti-retroviral therapy (HAART)
    Mkhize, N. N.
    Gumbi, P. P.
    Denny, L.
    Passmore, J.
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2010, 26 (10) : A84 - A85
  • [30] Effect of highly active antiretroviral therapy (HAART) on HIV associated hypergammaglobulinemia (HgG)
    Younus, F
    Morrison, SA
    Steigbigel, RT
    CLINICAL INFECTIOUS DISEASES, 2000, 31 (01) : 272 - 272
12345